First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome

Prenatal Diagnosis

Volumn 29, Issue 6, 2009, Pages 553-559

  Poon, Leona C Y ^a   Nekrasova, Ekaterina ^a   Anastassopoulos, Panagiotis ^a   Livanos, Panagiotis ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Matrix metalloproteinase 9; Preeclampsia; Preterm delivery; Uterine artery doppler

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; GELATINASE B; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SMALL FOR DATE INFANT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; YOUNG ADULT;

EID: 67049095826     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2234     Document Type: Article

References (26)

1. Athayde N, Romero R, Gomez R, et al. 1999. Matrix metalloproteinases- 9 in preterm and term human parturition. J Matern Fetal Med 8: 213-219.
2. Celik E, To M, Gajewska K, Smith GC, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. 2008. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 31: 549-554.
3. Davey DA, MacGillivray I. 1988. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158: 892-898.
4. Gardosi J, Francis A. 2006. Customised centile calculator - GROW-Centile v 5.1, Gestation Network, www.gestation.net.
5. Garfield RE, Saade G, Buhimschi C, et al. 1998. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update 4: 673-695.
6. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. 2001. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722.
7. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
8. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. 1994. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 170: 1752-1759.
9. Laursen LS, Overgaard MT, Soe R, et al. 2001. Pregnancy associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504: 36-40.
10. Lawrence JB, Oxvig C, Overgaard MT, et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy associated plasma protein-A. Proc Natl Acad Sci U S A 95: 3149-3153.
11. Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH. 2009. First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia. Ultrasound Obstet Gynecol 33: 135-141.
12. Librach CL, Werb Z, Fitzgerald ML, et al. 1991. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 113: 437-449.
13. Lockwood CJ, Oner C, Uz YH, et al. 2008. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic deciduas and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 78: 1064-1072.
14. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. 2003. The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol 189: 1173-1177.
15. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25: 221-226.
16. Pijnenborg R, Vercruysse L, Hanssens M. 2006. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27: 939-958.
17. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749.
18. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum PAPP-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
19. Redman CW, Sacks GP, Sargent IL. 1999. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 80: 499-506.
20. Sebire NJ, Goldin RD, Regan L. 2005. Term pre-eclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25: 117-118.
21. Smith GCS, Celik E, To M, Khouri O, Nicolaides KH. 2008. Cervical length at mid-pregnancy and the risk of primary cesarean delivery. N Engl J Med 358: 1346-1353.
22. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH, Fetal Medicine Foundation First Trimester Screening Group. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
23. Stamenkovic I. 2003. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200: 448-464.
24. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L. 2002. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 67: 889-894.
25. Tu FF, Goldenberg RL, Tamura T, Drews M, Zucker SJ, Fred Voss HF. 1998. Prenatal plasma matrix metalloproteinase-9 levels to predict spontaneous preterm birth. Obstet Gynecol 92: 446-449.
26. Vettriano LM, Roby J, Tolley T, Parks WC. 1996. Collagenase-1, stromelysin-1, and matrilysin are expressed within the placenta during multiple stages of human pregnancy. Placenta 17: 557-563.